CytomX Therapeutics, Inc. (CTMX) Financial Statements (2024 and earlier)

Company Profile

Business Address 151 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:182,362205,85695,574176,435175,670225,690
Cash and cash equivalents57,53656,357193,65095,036129,290163,488
Short-term investments123,322148,145 99,25498,87599,042
Other undisclosed cash, cash equivalents, and short-term investments1,5041,354(98,076)(17,855)(52,495)(36,840)
Receivables1,9031,09035,9861,7121,0141,016
Other undisclosed current assets3,5365,331105,54222,13356,08641,738
Total current assets:187,801212,277237,102200,280232,770268,444
Noncurrent Assets
Operating lease, right-of-use asset14,12615,04815,94916,83017,69218,536
Property, plant and equipment4,4994,5735,0725,7105,9156,093
Intangible assets, net (including goodwill)1,7511,7881,8241,8601,8971,933
Goodwill949949949949949949
Intangible assets, net (excluding goodwill)802839875911948984
Restricted cash and investments917917917917917917
Other noncurrent assets912727895895902
Total noncurrent assets:21,38422,35323,78926,21227,31628,381
TOTAL ASSETS:209,185234,630260,891226,492260,086296,825
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21,09724,47831,34142,84140,76132,753
Employee-related liabilities6,3257,109
Accounts payable1,0292,2032,8095,1761,9201,721
Accrued liabilities20,06822,27528,53231,34031,73231,032
Deferred revenue120,280126,784121,26761,32565,78770,013
Other undisclosed current liabilities    (6,325)(7,109) 
Total current liabilities:141,377151,262152,60897,84199,439102,766
Noncurrent Liabilities
Long-term debt and lease obligation:    15,05516,07617,077
Liabilities, other than long-term debt152,835170,005194,03485,12295,863108,788
Deferred revenue140,873157,133180,05985,12295,863108,788
Other liabilities216     
Operating lease, liability11,74612,87213,97515,05516,07617,077
Total noncurrent liabilities:152,835170,005194,034100,177111,939125,865
Total liabilities:294,212321,267346,642198,018211,378228,631
Equity
Equity, attributable to parent(85,027)(86,637)(85,751)28,47448,70868,194
Common stock111111
Additional paid in capital642,214639,526637,117634,357631,662626,721
Accumulated other comprehensive income (loss)352610(795)(1,162)(919)
Accumulated deficit(727,277)(726,190)(722,879)(605,089)(581,793)(557,609)
Total equity:(85,027)(86,637)(85,751)28,47448,70868,194
TOTAL LIABILITIES AND EQUITY:209,185234,630260,891226,492260,086296,825

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues24,72423,49994616,91518,16517,136
Gross profit:24,72423,49994616,91518,16517,136
Operating expenses(28,072)(29,152)(29,631)(40,857)(42,907)(41,102)
Operating income (loss):(3,348)(5,653)(28,685)(23,942)(24,742)(23,966)
Nonoperating income2,2612,34273364655881
Investment income, nonoperating2,3082,32773261626268
Other nonoperating income (expense)(47)1513029613
Income (loss) from continuing operations before income taxes:(1,087)(3,311)(27,952)(23,296)(24,184)(23,885)
Income tax expense      
Income (loss) from continuing operations:(1,087)(3,311)(27,952)(23,296)(24,184)(23,885)
Loss before gain (loss) on sale of properties:(23,296)(24,184)(23,885)
Net income (loss) available to common stockholders, diluted:(1,087)(3,311)(27,952)(23,296)(24,184)(23,885)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):(1,087)(3,311)(27,952)(23,296)(24,184)(23,885)
Comprehensive income (loss):(1,087)(3,311)(27,952)(23,296)(24,184)(23,885)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent916805367(243)(677)
Comprehensive income (loss), net of tax, attributable to parent:(1,078)(3,295)(27,147)(22,929)(24,427)(24,562)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: